Carola A.S. Arndt

Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803

Carola A.S. Arndt, Julie A. Stoner, Douglas S. Hawkins et al. · Journal of Clinical Oncology · 2009 · 367 citations · Full text

Medicine, Oncology, Pharmacology +11

Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study

Linda Granowetter, Richard B. Womer, Meenakshi Devidas et al. · Journal of Clinical Oncology · 2009 · 332 citations · Full text

Medicine, Oncology, Chemotherapy +15

Intensive Multiagent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, Irinotecan, and Radiation, in Patients With High-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group

Brenda J. Weigel, Elizabeth Lyden, James R. Anderson et al. · Journal of Clinical Oncology · 2015 · 220 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Douglas S. Hawkins, Yueh-Yun Chi, James R. Anderson et al. · Journal of Clinical Oncology · 2018 · 175 citations

Medicine, Oncology, Radiation Oncology +17

Fluconazole Penetration into Cerebrospinal Fluid: Implications for Treating Fungal Infections of the Central Nervous System

Carola A.S. Arndt, Thomas J. Walsh, Cynthia Lester McCully et al. · The Journal of Infectious Diseases · 1988 · 167 citations

Medicine, Infectious Diseases, Pharmacology +17